BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10552998)

  • 1. The role of different P-glycoproteins in hepatobiliary secretion of fluorescently labeled short-chain phospholipids.
    Frijters CM; Tuijn CJ; Ottenhoff R; Zegers BN; Groen AK; Elferink RP
    J Lipid Res; 1999 Nov; 40(11):1950-8. PubMed ID: 10552998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
    Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
    Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy.
    Crawford AR; Smith AJ; Hatch VC; Oude Elferink RP; Borst P; Crawford JM
    J Clin Invest; 1997 Nov; 100(10):2562-7. PubMed ID: 9366571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate. Implications for hepatic bile formation.
    Ruetz S; Gros P
    J Biol Chem; 1995 Oct; 270(43):25388-95. PubMed ID: 7592705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport.
    Beukeveld GJ; In 't Veld G; Havinga R; Groen AK; Wolthers BG; Kuipers F
    J Hepatol; 1996 Mar; 24(3):343-52. PubMed ID: 8778203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein.
    Oude Elferink RP; Ottenhoff R; van Wijland M; Frijters CM; van Nieuwkerk C; Groen AK
    J Lipid Res; 1996 May; 37(5):1065-75. PubMed ID: 8725158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric distribution of phosphatidylcholine and sphingomyelin between micellar and vesicular phases. Potential implications for canalicular bile formation.
    Eckhardt ER; Moschetta A; Renooij W; Goerdayal SS; van Berge-Henegouwen GP; van Erpecum KJ
    J Lipid Res; 1999 Nov; 40(11):2022-33. PubMed ID: 10553006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
    Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
    Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurocholate induces pericanalicular localization of C6-NBD-ceramide in isolated hepatocyte couplets.
    Crawford JM; Vinter DW; Gollan JL
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G119-32. PubMed ID: 1987800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent, short-chain C6-NBD-sphingomyelin, but not C6-NBD-glucosylceramide, is subject to extensive degradation in the plasma membrane: implications for signal transduction related to cell differentiation.
    Kok JW; Babia T; Klappe K; Hoekstra D
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):905-12. PubMed ID: 7639709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segregation of glucosylceramide and sphingomyelin occurs in the apical to basolateral transcytotic route in HepG2 cells.
    van IJzendoorn SC; Zegers MM; Kok JW; Hoekstra D
    J Cell Biol; 1997 Apr; 137(2):347-57. PubMed ID: 9128247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved assay for measuring the transverse redistribution of fluorescent phospholipids in plasma membranes.
    Pomorski T; Herrmann A; Zimmermann B; Zachowski A; Müller P
    Chem Phys Lipids; 1995 Aug; 77(2):139-46. PubMed ID: 7586098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse.
    Chianale J; Vollrath V; Wielandt AM; Amigo L; Rigotti A; Nervi F; Gonzalez S; Andrade L; Pizarro M; Accatino L
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):781-6. PubMed ID: 8615769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in
    Wang R; Sheps JA; Liu L; Han J; Chen PSK; Lamontagne J; Wilson PD; Welch I; Borchers CH; Ling V
    J Lipid Res; 2019 Jan; 60(1):85-97. PubMed ID: 30416103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of membrane microdomains for bile salt-dependent biliary lipid secretion.
    Eckstein J; Holzhütter HG; Berndt N
    J Cell Sci; 2018 Mar; 131(5):. PubMed ID: 29420298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of bile salts on hepatic mdr2 P-glycoprotein expression.
    Frijters CM; Ottenhoff R; Van Wijland MJ; Van Nieuwkerk C; Groen AK; Oude Elferink RP
    Adv Enzyme Regul; 1996; 36():351-63. PubMed ID: 8869755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular and nonvesicular transport of phosphatidylcholine in polarized HepG2 cells.
    Wüstner D; Mukherjee S; Maxfield FR; Müller P; Herrmann A
    Traffic; 2001 Apr; 2(4):277-96. PubMed ID: 11285138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice.
    Voshol PJ; Koopen NR; de Vree JM; Havinga R; Princen HM; Elferink RP; Groen AK; Kuipers F
    J Hepatol; 2001 Feb; 34(2):202-9. PubMed ID: 11281547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1).
    Dekkers DW; Comfurius P; Schroit AJ; Bevers EM; Zwaal RF
    Biochemistry; 1998 Oct; 37(42):14833-7. PubMed ID: 9778357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of Taurohyodeoxycholate-induced Biliary Phospholipid Efflux -Understanding the Function of the ABCB4 Enhancer for Developing Therapeutic Agents against Bile Salt-induced Liver Injury].
    Ikeda Y
    Yakugaku Zasshi; 2020; 140(11):1329-1334. PubMed ID: 33132268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.